长非编码RNA的异质表达RP11-109D20.2:洞察结肠癌中调节基因表达作用的洞察
Sara Chitgaran1, Reihaneh Alsadat Mahmoudian2, Seyed Saeed Khatami1
1Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Iranian journal of basic medical sciences
|July 16, 2025
概括
这项研究确定RP11-109D20.2是结直肠癌 (CRC) 中显著上调的长非编码RNA. 需要进一步的研究来探索其作为CRC进展的诊断生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症相关死亡的主要原因.
- 早期诊断和有效的治疗对于改善CRC结果至关重要.
- 长非编码RNAs (lncRNAs) 在CRC瘤发生中发挥着重要作用.
研究的目的:
- 确定共表达的lncRNA网络,用于CRC中的生物标志物预测.
- 通过实验验证最佳候选 lncRNA生物标记物.
- 调查 lncRNAs 在CRC进展中的作用.
主要方法:
- 重新分析公开的RNA测序数据 (BioProject PRJEB27536),以确定CRC中差异表达的lncRNAs (DElncRNAs).
- 利用生物信息学工具,如DESeq2,GSEA和WGCNA用于途径和基因网络分析.
- 使用RT-PCR对CRC患者组织中RP11-109D20.2的表达进行了定量评估.
主要成果:
- 在CRC和正常组织之间确定了17939个DElncRNA.
- 在CRC样本中观察到RP11-109D20.2 (48%) 的显著上调.
- 发现RP11-109D20.2与路径相关,包括乙烯氧化酶和氧降解酶活动;高的DUOX2表达与高RP11-109D20.2水平相关.
结论:
- RP11-109D20.2可能在结直肠癌的进展中发挥重要作用.
- 需要进一步的功能分析来验证RP11-109D20.2作为诊断标记.
- 研究RP11-109D20.2在CRC中循环核酸化酶基因失调中的作用是有必要的.
相关概念视频
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
RNA Splicing
57.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.1K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Regulation of Expression at Multiple Steps
1.0K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.0K
Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K


